200 related articles for article (PubMed ID: 36475023)
1. Proteomics reveals the potential mechanism of Tanshinone IIA in promoting the
Yuan P; Qin HY; Wei JY; Chen G; Li X
Regen Ther; 2022 Dec; 21():560-573. PubMed ID: 36475023
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia model.
Tong Y; Xu W; Han H; Chen Y; Yang J; Qiao H; Hong D; Wu Y; Zhou C
Phytomedicine; 2011 Apr; 18(6):443-50. PubMed ID: 21146968
[TBL] [Abstract][Full Text] [Related]
3. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Liu C; Li J; Wang L; Wu F; Huang L; Xu Y; Ye J; Xiao B; Meng F; Chen S; Yang M
BMC Complement Altern Med; 2012 Jan; 12():5. PubMed ID: 22248096
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA regulates fibroblast proliferation and migration and post-surgery arthrofibrosis through the autophagy-mediated PI3K and AMPK-mTOR signaling pathway.
Zhang Z; Zhu D; Zhang X; Liu Y; Wang J; Yan L
Am J Transl Res; 2021; 13(2):565-584. PubMed ID: 33594310
[TBL] [Abstract][Full Text] [Related]
5. Potential pharmacological mechanisms of tanshinone IIA in the treatment of human neuroblastoma based on network pharmacological and molecular docking Technology.
Tang N; Wang Y; Miao J; Zhao Y; Cao Y; Sun W; Zhang J; Sui H; Li B
Front Pharmacol; 2024; 15():1363415. PubMed ID: 38533261
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor (HGF) and stem cell factor (SCF) maintained the stemness of human bone marrow mesenchymal stem cells (hBMSCs) during long-term expansion by preserving mitochondrial function via the PI3K/AKT, ERK1/2, and STAT3 signaling pathways.
Cao Z; Xie Y; Yu L; Li Y; Wang Y
Stem Cell Res Ther; 2020 Jul; 11(1):329. PubMed ID: 32736659
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Su CC
Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
[TBL] [Abstract][Full Text] [Related]
8. The anticancer mechanism investigation of Tanshinone II
Cao YF; Wang SF; Li X; Zhang YL; Qiao YJ
BMC Syst Biol; 2018 Oct; 12(1):90. PubMed ID: 30373594
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA promotes the proliferation and differentiation ability of primary muscle stem cells via MAPK and Akt signaling.
Liu W; Wang T; Wang W; Lin X; Xie K
Biochem Biophys Res Commun; 2023 Dec; 689():149235. PubMed ID: 37976834
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling.
Feng F; Cheng P; Xu S; Li N; Wang H; Zhang Y; Wang W
Chem Biol Interact; 2020 Mar; 319():109024. PubMed ID: 32097614
[TBL] [Abstract][Full Text] [Related]
11. Quantitative iTRAQ proteomics reveal the proteome profiles of bone marrow mesenchymal stem cells after cocultures with Schwann cells
Ding H; Li A; Sun C; Zhang J; Shang J; Tang H; Li J; Wang M; Kong X; Wei Z; Feng S
Ann Transl Med; 2022 Sep; 10(18):962. PubMed ID: 36267768
[TBL] [Abstract][Full Text] [Related]
12. Effect of fibronectin, FGF-2, and BMP4 in the stemness maintenance of BMSCs and the metabolic and proteomic cues involved.
Chen L; Carlton M; Chen X; Kaur N; Ryan H; Parker TJ; Lin Z; Xiao Y; Zhou Y
Stem Cell Res Ther; 2021 Mar; 12(1):165. PubMed ID: 33676544
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K/AKT signaling pathway.
Lu L; Chen G; Yang J; Ma Z; Yang Y; Hu Y; Lu Y; Cao Z; Wang Y; Wang X
Biomed Pharmacother; 2019 Apr; 112():108625. PubMed ID: 30784920
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
Su CC
Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA promotes the differentiation of bone marrow mesenchymal stem cells into neuronal-like cells in a spinal cord injury model.
Zhang XM; Ma J; Sun Y; Yu BQ; Jiao ZM; Wang D; Yu MY; Li JY; Fu J
J Transl Med; 2018 Jul; 16(1):193. PubMed ID: 30001730
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
17. The Protective Role of Tanshinone IIA in Silicosis Rat Model via TGF-β1/Smad Signaling Suppression, NOX4 Inhibition and Nrf2/ARE Signaling Activation.
Feng F; Cheng P; Zhang H; Li N; Qi Y; Wang H; Wang Y; Wang W
Drug Des Devel Ther; 2019; 13():4275-4290. PubMed ID: 31908414
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA induces apoptosis and autophagy in acute monocytic leukemia via downregulation of PI3K/Akt pathway.
Zhang Y; Geng Y; He J; Wu D; Zhang T; Xue L; Zhang L; He A
Am J Transl Res; 2019; 11(5):2995-3006. PubMed ID: 31217869
[TBL] [Abstract][Full Text] [Related]
19. Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways.
Pan C; Lou L; Huo Y; Singh G; Chen M; Zhang D; Wu A; Zhao M; Wang S; Li J
Ther Adv Cardiovasc Dis; 2011 Apr; 5(2):99-111. PubMed ID: 21282198
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
